Literature DB >> 3918101

Failure of OKT3 monoclonal antibody to induce lymphocyte mitogenesis: a familial defect in monocyte helper function.

J L Ceuppens, L Meurs, J P Van Wauwe.   

Abstract

Monoclonal antibodies to the T3 molecule on human T cells have mitogenic activity. Although anti-T3 antibodies of the IgG1 subclass (e.g., UCHT1) induce mitogenesis in lymphocyte cultures from only 60 to 70% of normal donors, antibodies of Ig2a subclass (e.g., OKT3) invariably have been found to be mitogenic in all subjects tested up to the present. This paper describes a family (a mother, six daughters, and one son) in which five members failed to respond mitogenically to OKT3 although the proportion of OKT3-reactive cells in their peripheral blood was normal. Mitogenic responses to PHA, Con A, and PWM were normal. Five members comprising four OKT3 nonresponders were also unresponsive to UCHT1. Unresponsiveness to OKT3 and unresponsiveness to UCHT1 were not absolutely linked to each other, nor were they linked to an HLA haplotype inherited from the mother. Upon stimulation by OKT3, lymphocyte preparations from OKT3-nonresponders failed to produce interleukin 2 (IL 2) and to display IL 2 receptors. OKT3 unresponsiveness was due to defective monocyte help: thus, responsiveness to OKT3 of T cells from an OKT3-nonresponder was restored by the addition of monocytes from an HLA-identical sister who had a normal response to OKT3. Inversely, T cells from the OKT3 responder had no reactivity to OKT3 when cultured in the presence of monocytes from an HLA-identical, OKT3-nonresponsive sister. Unresponsiveness to OKT3 could not be overcome by the addition of phorbol myristate acetate to the cultures. These data on a familial, non-HLA-linked deficiency of monocytes to exert their auxiliary function provide better insight into the mechanism of anti-T3-induced T cell activation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918101

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  The role of OKT3 in clinical transplantation.

Authors:  D J Norman; M R Leone
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

2.  Stimulation of mucosal T cells in situ with anti-CD3 antibody: location of the activated T cells and their distribution within the mucosal micro-environment.

Authors:  T Monk; J Spencer; N Cerf-Bensussan; T T MacDonald
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

3.  Defect in the membrane expression of high affinity 72-kD Fc gamma receptors on phagocytic cells in four healthy subjects.

Authors:  J L Ceuppens; M L Baroja; F Van Vaeck; C L Anderson
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

4.  Effects of an FcγRIIA polymorphism on leukocyte gene expression and cytokine responses to anti-CD3 and anti-CD28 antibodies.

Authors:  Michelle M Stein; Cara L Hrusch; Anne I Sperling; Carole Ober
Journal:  Genes Immun       Date:  2018-07-06       Impact factor: 2.676

5.  Construction and characterization of a humanized anti-human CD3 monoclonal antibody 12F6 with effective immunoregulation functions.

Authors:  Bohua Li; Hao Wang; Jianxin Dai; Junjie Ji; Weizhu Qian; Dapeng Zhang; Sheng Hou; Yajun Guo
Journal:  Immunology       Date:  2005-12       Impact factor: 7.397

6.  Increased proportion of responders to a murine anti-CD3 monoclonal antibody of the IgG1 class in patients with systemic lupus erythematosus (SLE).

Authors:  A M Blasini; I L Stekman; M Leon-Ponte; D Caldera; M A Rodriguez
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

7.  Characterization of polymorphic forms of Fc receptor III on human neutrophils.

Authors:  P A Ory; I M Goldstein; E E Kwoh; S B Clarkson
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

8.  Opsonin-independent ligation of Fc gamma receptors. The 3G8-bearing receptors on neutrophils mediate the phagocytosis of concanavalin A-treated erythrocytes and nonopsonized Escherichia coli.

Authors:  J E Salmon; S Kapur; R P Kimberly
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.